🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will test the effectiveness (rate of complete remissions, total r...
Status
Completed
Location
Community based hemato-oncology medical office
Start Date
2004-06
Trial ID
NCT02157181
Treatments Being Tested
In this study, the investigators conducted a phase II trial that evaluated ...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2021-03-01
Trial ID
NCT04254640
Treatments Being Tested
Acute myeloid leukemia (AML) is a bone marrow cancer that is challenging to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-15
Trial ID
NCT07423104
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
The trial will test the effectiveness and toxicity of subcutaneous treatmen...
Status
Recruiting
Location
Community based hemato-oncology medical office
Start Date
2004-05
Trial ID
NCT02131753
Treatments Being Tested
Acute myeloid leukemia (AML) is one of the most common hematologic malignan...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-04-01
Trial ID
NCT07500753
Treatments Being Tested
The goal of this clinical research study is to see how well the drugs 2CdA,...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
1999-07-09
Trial ID
NCT00667329
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of subcutan...
Status
Recruiting
Location
Institute of Psychiatry and Neurology
Start Date
2022-10-03
Trial ID
NCT05961644
Treatments Being Tested
To learn if the combination of cladribine, cytarabine, venetoclax, and azac...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-09-23
Trial ID
NCT05365035
Treatments Being Tested
This is a prospective phase II clinical study planned to be conducted at th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2017-06-14
Trial ID
NCT03150004